KRAS G13D mutation and sensitivity to cetuximab or panitumumab in a colorectal cancer cell line model

Sree Kumar, S.Price, T.Mohyieldin, O.Borg, M.Townsend, A.Hardingham, J.2015-05-192015-05-192014Gastrointestinal cancer research : GCR, 2014; 7(1):23-261934-78201934-7987http://hdl.handle.net/2440/91197Abstract not availableen© 2014 by International Society of Gastrointestinal OncologyKRAS G13D mutation and sensitivity to cetuximab or panitumumab in a colorectal cancer cell line modelJournal article00300138762-s2.0-84894592709108378Price, T. [0000-0002-3922-2693]Borg, M. [0000-0003-4741-553X]Townsend, A. [0000-0003-3563-4719]Hardingham, J. [0000-0001-8277-1199]